BIB holdings — ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (BIB) held 267 positions with net assets of $73.7M as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 43.0% of the fund, led by N/A, IQMM, GILD.
BIB top holdings
- N/A — 7.35% ($5.42M)
- IQMM ProShares GENIUS Money Market ETF — 6.80% ($5.01M)
- GILD Gilead Sciences, Inc. — 4.66% ($3.43M)
- VRTX Vertex Pharmaceuticals, Inc. — 4.65% ($3.43M)
- AMGN Amgen, Inc. — 4.48% ($3.30M)
- N/A — 3.94% ($2.90M)
- N/A — 3.26% ($2.40M)
- REGN Regeneron Pharmaceuticals, Inc. — 3.21% ($2.36M)
- N/A — 2.62% ($1.93M)
- ALNY Alnylam Pharmaceuticals, Inc. — 2.01% ($1.48M)
- RVMD Revolution Medicines, Inc. — 1.57% ($1.15M)
- BIIB Biogen, Inc. — 1.44% ($1.06M)
- Repurchase Agreement — 1.28% ($945K)
- ILMN Illumina, Inc. — 1.25% ($921K)
- UTHR United Therapeutics Corp. — 1.22% ($902K)
- Royalty Pharma plc — 1.20% ($883K)
- ARGX Argenx SE — 1.19% ($878K)
- N/A — 1.18% ($871K)
- INSM Insmed, Inc. — 1.16% ($852K)
- Roivant Sciences Ltd. — 1.08% ($794K)
- INCY Incyte Corp. — 0.97% ($712K)
- VTRS Viatris, Inc. — 0.94% ($692K)
- MRNA Moderna, Inc. — 0.94% ($689K)
- GH Guardant Health, Inc. — 0.85% ($629K)
- INVESCO GOVT AND AGCY LEX — 0.81% ($598K)
What are BIB's top 10 holdings?
N/A (7.4%), IQMM (6.8%), GILD (4.7%), VRTX (4.7%), AMGN (4.5%), N/A (3.9%), N/A (3.3%), REGN (3.2%), N/A (2.6%), ALNY (2.0%).
How many stocks are in BIB?
ProShares Ultra Nasdaq Biotechnology reported 267 holdings as of May 31, 2026.